iPLATO Mobile Health Services Reaches 5 Million Patients in the UK

iPLATO HealthcareiPLATO Healthcare, a UK leader in mHealth, revealed that the number of patients connected to its platform surpassed five million in late 2012. Working in partnership with healthcare commissioners, commissioning support teams and practices iPLATO added over 5,000 patients per day to the platform in 2012. The company attributes the accelerated uptake to growing patient and practitioner acceptance for mobile services as well as maturing business cases for increased provider productivity, improved public health promotion and transformed support to people with long term conditions. iPLATO expects its British network to reach 10 million patients within 2 years. The company is looking for partners to establish networks in other countries.

Tobias Alpsten, CEO of iPLATO, said: "Continued support from healthcare commissioners across the NHS has been an instrumental in enabling us to reach our first five million patients. However, this is only a step on the way. There are more than 6 billion mobile handsets in the world today, each owned by a person for whom health is important, so there is a lot of room for growth. In addition to our in-house research and development efforts we actively seek partners with specific clinical skills to add to our overall service offering. We owe our healthcare provider partners and patients best-of-breed services. We expect many of these new, exiting, services to be delivered in partnership with universities, hospitals, clinical experts and other innovation companies across the world. We are especially interested in services that support people with long term conditions such as hypertension, diabetes, asthma, depression and coronary heart disease."

Related news articles:

About iPLATO
iPLATO Healthcare is British innovation company dedicated to mobile health since 2006.

iPLATO's evidence based mobile health solutions have proven to improve patient access to healthcare, to enable powerful health promotion targeted at people at risk and to support people with long term conditions.

Serving millions of patients and thousands of healthcare professionals every day iPLATO has emerged as the leader in mobile health. Across this network the company is running campaigns to promote smoking cessation, weight loss, childhood immunisation and cancer screening as well as mobile disease management services for people with epilepsy, COPD and HIV.

iPLATO Healthcare's mission is to, in partnership with healthcare professionals and provider organisations, support patients in achieving longer, healthier lives.

Most Popular Now

MEDICA 2024 + COMPAMED 2024: Adapted Hal…

11 - 14 November 2024, Düsseldorf, Germany. The final preparations for MEDICA 2024 and COMPAMED 2024 in Düsseldorf have begun. A total of more than 5,500 exhibitors from approximately 70 countries...

AI does Not Necessarily Lead to more Eff…

The use of artificial intelligence (AI) in hospitals and patient care is steadily increasing. Especially in specialist areas with a high proportion of imaging, such as radiology, AI has long...

Commission Joins Forces with Venture Cap…

The Commission has launched a Trusted Investors Network bringing together a group of investors ready to co-invest in innovative deep-tech companies in Europe together with the EU. The Union's investment...

Why the NHS is Seeking to Make Media Ser…

Opinion Article by Dean Moody, Healthcare Services Director, Airwave Healthcare. Tim Kelsey and Martha Lane Fox called for WiFi to be made available free of charge throughout the NHS back in...

An AI-Powered Pipeline for Personalized …

Ludwig Cancer Research scientists have developed a full, start-to-finish computational pipeline that integrates multiple molecular and genetic analyses of tumors and the specific molecular targets of T cells and harnesses...

Philips and Medtronic Advocacy Partnersh…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies, today announced a strategic advocacy partnership. Delivering timely stroke...

Wearable Cameras Allow AI to Detect Medi…

A team of researchers says it has developed the first wearable camera system that, with the help of artificial intelligence (AI), detects potential errors in medication delivery. In a test whose...

AI could Transform How Hospitals Produce…

A pilot study led by researchers at University of California San Diego School of Medicine found that advanced artificial intelligence (AI) could potentially lead to easier, faster and more efficient...

New AI Tool Predicts Protein-Protein Int…

Scientists from Cleveland Clinic and Cornell University have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication. The computational tool...

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...

G-Cloud 14 Makes it Easier for NHS to Bu…

NHS organisations will be able to save valuable time and resource in the procurement of technologies that can make a significant difference to patient experience, in the latest iteration of...